Quantum Cyber N.V. Interest Paid Classified As Financing Activities
Quantum Cyber N.V. (QUCY) reported Interest Paid Classified As Financing Activities of $190.00 thousand for the 6-month period ending 2024-06-30, per its 6-K filed 2024-10-18.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:InterestPaidClassifiedAsFinancingActivities · last filed 2024-10-18
- Quantum Cyber N.V. interest paid classified as financing activities for the quarter ending 2023-09-30 was $667.60K.
| Period end | Interest Paid Classified As Financing Activities 3 month | Interest Paid Classified As Financing Activities 6 month | Interest Paid Classified As Financing Activities 9 month |
|---|---|---|---|
| 2024-06-30 | $190.00K 6-K · filed 2024-10-18 | ||
| 2023-09-30 | $667.60K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | $772.42K 6-K · filed 2023-11-16 | |
| 2023-06-30 | $104.82K 6-K · filed 2024-10-18 | ||
| 2022-09-30 | $107.03K 6-K · filed 2023-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |